Let us not forget the important role of academic spinouts in innovating across the modalities.

Our latest news roundup reports on Vinay Prasad’s appointment, a personalized gene therapy for a baby with an ultra-rare condition, and more.

Researchers use AI to produce synthetic pharmacokinetic data.

Capacity has been built for cell and gene therapy manufacturing, but will demand keep pace? CDMOs may face a battle for survival.

When it comes to continuous cGMP biomanufacturing, Just – Evotec Biologics’ J.DESIGN platform integrates data analytics and continuous manufacturing

Can digital tools help lower the carbon footprint of a clinical trial? First, we need more data.

Trump continues to send shockwaves through the industry. We look at FDA disruption, tariffs, funding volatility, and more.

Galimedix Therapeutics explains how small molecule drug candidates could provide new treatments for Alzheimer’s disease and beyond.

We speak with an advocate for alternative drug testing methods about the challenges that lie ahead.

Many US researchers are at odds with the imposition of Trump’s political agendas. EU member states are looking to take advantage.